CHINA PHARMA HOLDINGS, INC. Other Restricted Assets, Current
CHINA PHARMA HOLDINGS, INC. (CPHI) had Other Restricted Assets, Current of $14.51 thousand as of 2017-03-31, per its 10-Q filed 2017-05-11.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Restricted Cash and Investments, Current
us-gaap:OtherRestrictedAssetsCurrent · last filed 2017-05-11
- 2017-03-31: Other Restricted Assets, Current $14.51K.
- 2016-12-31: Other Restricted Assets, Current $0.00.
- 2016-09-30: Other Restricted Assets, Current $21.55K.
- 2016-06-30: Other Restricted Assets, Current $7.53K.
| Period end | Other Restricted Assets, Current |
|---|---|
| 2017-03-31 | $14.51K 10-Q · filed 2017-05-11 |
| 2016-12-31 | $0.00 10-Q · filed 2017-05-11 |
| 2016-09-30 | $21.55K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $7.53K 10-Q · filed 2016-08-11 |
| 2016-03-31 | $116.32K 10-Q · filed 2016-05-16 |
| 2015-12-31 | $0.00 10-Q · filed 2016-11-14 |
| 2015-09-30 | $312.80K 10-Q · filed 2015-12-28 |
| 2015-06-30 | $90.33K 10-Q · filed 2015-12-28 |
| 2015-03-31 | $120.77K 10-Q · filed 2015-12-28 |
| 2014-12-31 | $458.23K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |